Evidence map›Paper›PMID 34498218›Full record

ArticleBrazilian journal of microbiology : [publication of the Brazilian Society for Microbiology]2021

Epidemiological and molecular profile of blood donors infected with HTLV-1/2 in the state of Pará, northern Brazil.

Carolina de Alcantara Maneschy, Katarine Antonia Dos Santos Barile, Jairo Augusto Américo de Castro, Maurício Koury Palmeira, Renata Bezerra Hermes de Castro, Carlos Eduardo de Melo Amaral

Abstract read
In one paragraph

Article in Brazilian journal of microbiology : [publication of the Brazilian Society for Microbiology], 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed.

  1. Article
  2. Article
  3. Human T-lymphotropic virus 2 (HTLV-2) prevalence of blood donors in the state of Pará, Brazil.Brazilian journal of microbiology : [publication of the Brazilian Society for Microbiology] · 2023
    Article
  4. Article
  5. Molecular characterization of Human T-cell Lymphotropic Viruses 1 and 2 (HTLV-1 and HTLV-2) in samples from blood donation candidates in the state of Pará, Brazilian Amazon.The Brazilian journal of infectious diseases : an official publication of the Brazilian Society of Infectious Diseases
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Carolina de Alcantara ManeschyCenter for Hemotherapy and Hematology of Para, Belém, Pará, 66033-000, Brazil. camaneschy@gmail.com.ORCID http://orcid.org/0000-0002-1384-9180
Katarine Antonia Dos Santos BarileCenter for Hemotherapy and Hematology of Para, Belém, Pará, 66033-000, Brazil.ORCID http://orcid.org/0000-0002-2229-6186
Jairo Augusto Américo de CastroCenter for Hemotherapy and Hematology of Para, Belém, Pará, 66033-000, Brazil.ORCID http://orcid.org/0000-0002-2522-5041
Maurício Koury PalmeiraCenter for Hemotherapy and Hematology of Para, Belém, Pará, 66033-000, Brazil.ORCID http://orcid.org/0000-0002-5675-7307
Renata Bezerra Hermes de CastroCenter for Hemotherapy and Hematology of Para, Belém, Pará, 66033-000, Brazil.ORCID http://orcid.org/0000-0001-7732-2401
Carlos Eduardo de Melo AmaralCenter for Hemotherapy and Hematology of Para, Belém, Pará, 66033-000, Brazil.ORCID http://orcid.org/0000-0003-1245-3851

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundThe Human T-lymphotropic virus (HTLV) is a retrovirus of the genus Deltaretrovirus, which belongs to the family Retroviridae. The most important types are HTLV-1 and HTLV-2. It is estimated that between five and 10 million individuals are infected with HTLV-1, worldwide. Studies in the state of Pará indicate that it has the third highest prevalence of HTLV infections of any Brazilian state. The present study describes the epidemiological, serological, and molecular profile of blood donors from the state of Pará that were classified as unfit due to infection by HTLV-1 and 2.

methodsThe present study is based on a descriptive, retrospective, and cross-sectional review of the epidemiological, serological, and molecular data on blood donations, between January 2015 and December 2019. The data were obtained from the blood bank system and were digitalized to form a database in the Statistical Package for Social Sciences program, version 20. Descriptive statistics were used to determine the absolute and relative frequencies of the qualitative variables. For the quantitative variables, the mean, standard deviation, and minimum and maximum values were calculated. A p < 0.05 significance level was adopted for all analyses.

resultsA total of 632 samples were analyzed, of which 496 (78%) had no detectable proviral DNA and 136 (22%) had detectable HTLV. The HTLV-1 was detected in most (78%; 106/136) of these samples, while only 30 (22%) were detected for HTLV-2. The HTLV proviral DNA was detected primarily in females (69.1%), with a mean age of 40 years, with the highest frequencies of detection being recorded in single individuals (66.2%), first-time donors (74.3%), and individuals that had graduated high school (44.1%). The molecular confirmation of HTLV showed that three-quarters (78%) of the serologically reactive individuals were negative for either types 1 or 2, so the epidemiological profile of these individuals was significantly different from their detectable profile.

conclusionsThe HTLV is neglected in Brazil; there is thus a clear need for further research in the area of regional hemotherapy and hematology services, in order to contribute to the definition of regional infection profiles, that will be fundamental to the development of effective prophylactic practices for the prevention of the infection and the dissemination of knowledge on the dangers of HTLV in the community.

Indexed as

Blood DonorsHTLV-I InfectionsHuman T-lymphotropic virus 1Human T-lymphotropic virus 2AdultBrazilCross-Sectional StudiesFemaleHumansRetrospective StudiesBlood donorsHTLV-1HTLV-2Molecular epidemiology

Identifiers

PMID34498218
PMCPMC8578528

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.